The aberrant high DLL3 expression in SCLC leads to its binding to Notch receptors and the disruption of the balance of Notch signaling, resulting in the downregulation of the Notch target genes HES1 and HEY1, promoting the development of SCLC [36]. The gene discussed is HEY1; the disease is small cell lung carcinoma.